05:38 PM EDT, 08/21/2024 (MT Newswires) -- Clearmind Medicine ( CMND ) shares were up 16% in recent after-hours activity Wednesday after the company said it received a new patent approval from the US Patent and Trademark Office for its proprietary binge behavior regulator program.

The patent covers Clearmind's innovative psychedelic molecule 5-methoxy-2-aminoindan, among other things, according to the company.

The latest patent expands the company's intellectual property portfolio to 29 patents across 19 patent families, Clearmind added.

Price: 1.5200, Change: +0.22, Percent Change: +16.92